Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.770
0.00 (0.00%)
At close: Dec 23, 2025
Genomtec Revenue
Genomtec had revenue of 4.00K PLN in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 15.00K, up 1,400.00% year-over-year. In the year 2024, Genomtec had annual revenue of 1,000.00.
Revenue (ttm)
15.00K
Revenue Growth
+1,400.00%
P/S Ratio
3,786.24
Revenue / Employee
576.92
Employees
26
Market Cap
56.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | - | - |
| Dec 31, 2023 | 1,000.00 | -39.00K | -97.50% |
| Dec 31, 2022 | 40.00K | -179.00K | -81.74% |
| Dec 31, 2021 | 219.00K | 199.00K | 995.00% |
| Dec 31, 2020 | 20.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 681.60M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |